Skip to main content
SpringerLink
Log in

Etanercept

Soluble Tumour Necrosis Factor Receptor, TNF Receptor Fusion Protein, TNFR-Fc, TNR 001, Enbrel®

  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wee S, Pascual M, Eason JD, et al. Biological effects and fate of a soluble, dimeric, 80-kDa tumor necrosis factor receptor in renal transplant recipients who receive OKT3 therapy. Transplantation 1997 Feb 27; 63: 570–7

    Article  PubMed  CAS  Google Scholar 

  2. Moreland LW, Saway PA, Jacobs C, et al. Soluble tumor necrosis factor receptor (sTNFR): results of a phase I dose-escalation study in patients with rheumatoid arthritis. Clin Res 1994 Apr; 42: 312A

    Google Scholar 

  3. Moreland LW, Baumgartner SW, Schiff MH, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997 Jul 17; 337: 141–7

    Article  PubMed  CAS  Google Scholar 

  4. ENBREL study suggests six-month administration is safe preliminary results from ongoing safety study presented at ACR meeting. PR Newswire [online].: [2 pages], 11 Apr 1997. Available from: URL: http://www.newspage.com

    Google Scholar 

  5. Moreland LW, Margolies G, Heck Jr et al. Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis. J Rheumatol 1996 Nov; 23: 1849–55

    PubMed  CAS  Google Scholar 

  6. Weinblatt M, Moreland LW, Schiff MH, et al. Longterm and phase III treatment of DMARD failing rheumatoid arthritis patients with TNF receptor P75 fusion protein (TNFR:FC; Enbrel(Rm)). Arthritis Rheum 1997 Sep; 40 Suppl.: 126

    Google Scholar 

  7. Moreland LW, Baumgartner SW, Tindall EA, et al. Longterm treatment of DMARD failing rheumatoid arthritis patients with TNF receptor p75 FC fusion protein (EnbrelRm). J Investig Med 1998 Mar; 46: 229

    Google Scholar 

  8. Molossi S, Clausell N, Sett S, et al. Effects of the TNF-alpha blockade and CsA in the expression of VCAM-1, ICAM-1 and fibronectin in rabbit cardiac allograft vasculopathy. J Heart Lung Transplant 1994 Jan–Feb; 13 Pt 2: 84

    Google Scholar 

  9. Eason JD, Wee S, Kawai T, et al. Inhibition of the effects of TNF in renal allograft recipients using recombinant human dimeric tumor necrosis factor receptors. Transplantation 1995 Jan 27; 59: 300–5

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Etanercept. Drugs R&D 1, 75–77 (1999). https://doi.org/10.2165/00126839-199901010-00025

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199901010-00025

Keywords

Search

Navigation